Lipoprotein compositional abnormalities in type I diabetes: Effect of improved glycaemic control

Diabetes Research and Clinical Practice

Volumn 36, Issue 2, 1997, Pages 83-90

  Pérez, Antonio ^a   Caixàs, Assumpta ^a   Carreras, Gemma ^a   Mauricio, Dídac ^a   Pou, Josep Maria ^a   Serrat, Josep ^a   Gómez Gerique, Juan ^a   De Leiva, Alberto ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Intensive insulin therapy; Lipoprotein composition; Lipoproteins; Type I diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; ISOPHANE INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0342894775     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00033-8     Document Type: Article

References (34)

1. K.M. West, M.M.S. Ahuja, P. Bennett et al, The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic populations from the WHO multinational study, Diabetes Care 6 (1983) 361-369.
2. F.L. Dunn, Plasma lipid and lipoprotein disorders in IDDM, Diabetes 41 (2) (1992) 102-106.
3. M.F. Lopes-Virella, H.J. Wohltmann, R.K. Mayfield, et al., Effect of metabolic control on lipid, lipoprotein and apolipoprotein levels in 55 insulin-dependent diabetic patients: A longitudinal study, Diabetes 32 (1983) 20-24.
4. J.D. Bagdade, E. Helve, M.R. Taskinen, Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus, Metabolism 40 (1991) 445-449.
5. M. Kobbah, B. Vessby, T. Tuvemo, Serum lipids and apolipoproteins in children with type I diabetes during the first 2 years of the disease, Diabetologia 31 (1988) 195-200.
6. B. Gonen, N. White, G. Schonfeld et al., Plasma levels of apoprotein B in patients with diabetes mellitus: The effect of glycemic control, Metabolism 34 (1985) 675-679.
7. J. Rosenstock, G.L. Vega, P. Raskin, Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes, Diabetes 37 (1988) 393-397.
8. P. Pauciullo, P. Rubba, G. Marotta, et al., Abnormalities in serum lipoprotein composition in patients with premature coronary heart disease compared to serum lipid matched controls. Atherosclerosis (1988) 241-246.
9. M.R. Taskinen, Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus, Diabetes 4 (2) (1992) 12-17.
10. P.H. Winocour, P.N. Durrington, D. Bhatnagar, et al., Abnormalities of VLDL, IDL and LDL characterize insulin-dependent diabetes mellitus, Arterioscl Tromb 12 (1992) 920-928.
11. A. Rivellese, G. Riccardi, G. Romano, et al., Presence of very low density lipoprotein compositional abnormalities in type I diabetic patients: effects of blood glucose optimization, Diabetologia 31 (1988) 884-888.
12. J.D. Bagdade, F.L. Dunn, Effects of insulin treatment on lipoprotein composition and function in patients with IDDM, Diabetes 4 (2) (1992) 107-110.
13. S. Sans, I. Balaguer, Programa Cronicat: Experiencia en la prevención de enfermedades cardiovasculares, Rev Clin Esp 180 (1987) 35-37.
14. N. Fontanals-Ferrer, J. Serrat-Serrat, A. Sorribas-Vivas, et al., Quick method of determining lipoproteins, including those of intermediate density, in serum, Clin Chem 34 (9) (1988) 1753-1757.
15. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 72 (1976) 248-254.
16. J.J. Albers, P.W. Whal, V.G. Cabana, Quantification of apolipoprotein A-I of human high density lipoprotein, Metabolism 25 (1976) 633-644.
17. J.A. Gómez, J. Serrat, A. Sorribas, C. González, F. González, Estudio de un método de inmunodifusion radial para la determinación de apolipoproteína AI, Quim Clin 7 (1988) 21-28.
18. C.C. Heuck, G. Schlierf, Simplified immunonephelometric quantitation of apolipoprotein B in hyperlipoproteinemic serum, Clin Chem 25 (1979) 782-785.
19. R.W. James, D. Pometta, Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects, Diabetes 39 (1990) 1158-1164.
20. G. Ruotolo, M. Parlavecchia, M.R. Taskinen, et al., Normalization of lipoprotein composition by intraperitoneal insulin in IDDM, Diabetes Care 17 (1) (1994) 6-12.
21. J.D. Bagdade, P.V. Subbaiah, Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men, Diabetes 38 (1989) 1226-1230.
22. K. Hiramatsu, E.L. Bierman, A. Chait, Metabolism of low-density-lipoprotein from patients with hypertriglyceridemia by cultured human skin fibroblast, Diabetes 34 (1985) 8-14.
23. M.A. Austin, J.L. Breslow, C.H. Hennekens, J.E. Buring, W.C. Willett, R.M. Krauss, Low-density lipoproteins subclass patterns and risk of miocardial infarction, JAMA 260 (1988) 1917-1921.
24. H.N. Ginsberg, Lipoprotein physiology in nondiabetic and diabetic states, Diabetes Care 14 (1991) 839-855.
25. G. Scherthaner, G.M. Kostner, H. Dieplinger, H. Prager, I. Mulhauser, Apolipoproteins (Apo A-I, A-II, B), Lp(a) lipoprotein and lecitin: Cholesterol acyltransferase activity in diabetes mellitus, Atherosclerosis 49 (1983) 277-293.
26. R.H. Eckel, Lipoprotein lipases and diabetes mellitus, in: B. Draznin, R.H. Eckel (Eds.), Diabetes and Atherosclerosis. Molecular Basis and Clinical Aspects. Elsevier, New York, 1993, pp. 77-102.
27. E.A. Nikkila, J.K. Huttunen, C. Ehnholm, Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism, Diabetes 26 (1977) 11-21.
28. A.O. Pietri, F.L. Dunn, P. Raskin, S.M. Grundy, The effect of continuous subcutaneous insulin infusion and very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus, Diabetes 32 (1983) 75-81.
29. F.L. Dunn, P.B. Carroll, W.F. Beltz, Treatment with artificial B cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes, Diabetes 36 (1987) 661-666.
30. J.D. Bagdade, M.C. Ritter, P.V. Subbaiah, Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus, Eur J Clin Invest 21 (1991) 161-167.
31. R.J. Havel, The formation of LDL. Mechanisms and regulation, J Lipid Res 25 (1984) 1570-1576.
32. W.C. Breckenridge, J.A. Little, P. Alaupovic, Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase, Atherosclerosis 45 (1982) 161-179.
33. G. Ruotolo, P. Micossi, G. Galimberti, et al., Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes, Metabolism 39 (6) (1990) 598-604.
34. A. Georgopoulos, C.D. Saudek, Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable. Implantable medication system, Diabetes Care 15 (1992) 19-26.